Marcaine With Epinephrine Injection, Solution
Product Images NDC 0404-9908

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Marcaine With Epinephrine (NDC 0404-9908). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

Chemical structure of bupivacaine hydrochloride, showing its molecular components including a piperidine ring, aromatic ring with methyl groups, and associated hydrochloride and water molecules.*

FDA Label Image

Formula2.jpg (Formula2)

Chemical structure diagram of epinephrine bitartrate, showing the molecular arrangement including benzene ring with hydroxyl groups and side chain with hydroxyl and amine groups.*

FDA Label Image

Image1.jpg (Image1)

This text panel lists various usage concentrations of Marcaine with Epinephrine (bupivacaine hydrochloride and epinephrine bitartrate) for different anesthesia blocks, including local infiltration, peripheral nerve block, retrobulbar block, sympathetic block, lumbar epidural, caudal, epidural test dose, and dental blocks, with specific percentage strengths noted for each use.*

FDA Label Image

Image2.jpg (Image2)

A boxed safety warning panel for Marcaine with Epinephrine injection. It states that the 0.75% concentration of Marcaine is not recommended for obstetrical anesthesia due to risks of cardiac arrest and difficulty in resuscitation. It advises reserving this concentration for surgical procedures needing high muscle relaxation and prolonged effect.*

FDA Label Image

Image3.jpg (Image3)

A data table listing drug classes alongside example drugs. The classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs. Each class is paired with example medications relevant to that category.*

FDA Label Image

Image4.jpg (Image4)

A data table titled 'Recommended Concentrations and Doses of MARCAINE' displaying concentrations, dose volumes (mL), dose amounts (mg), and motor block effects for different types of nerve blocks including local infiltration, epidural, caudal, peripheral nerves, retrobulbar, sympathetic, dental, and epidural test dose. The table differentiates concentrations with or without epinephrine and provides footnotes clarifying usage details and precautions.*

FDA Label Image

Image5.jpg (Image5)

A data table listing unit of sale, concentration, and packaging details for bupivacaine hydrochloride injections. It shows multiple strengths (0.25%, 0.5%, 0.75%) with corresponding mg/mL and total mg per vial, package sizes (tray of 10, carton of 1 or 10), and vial types (single-dose or multiple-dose). NDC codes are included for each package configuration.*

FDA Label Image

Image6.jpg (Image6)

A data table listing unit sales, concentrations, and packaging details for bupivacaine hydrochloride and epinephrine bitartrate injection solutions. It includes NDC codes, carton sizes, vial types, and concentration strengths for two formulations: 0.25% with epinephrine 1:200,000 (2.5 mg/mL) and 0.5% with epinephrine 1:200,000 (5 mg/mL). Package sizes vary from single-dose to multiple-dose vials.*

FDA Label Image

Label1.jpg (Label1)

MARCAINE WITH EPINEPHRINE 2.5 mg/mL injection, solution in a 30 mL single dose vial. The label indicates the product contains bupivacaine hydrochloride and epinephrine (75 mg/30 mL), for infiltration, nerve block, caudal, and epidural anesthesia. It is labeled by Henry Schein, Inc. with storage instructions and warnings about sulfites and epinephrine stability.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.